[go: up one dir, main page]

WO2007135406A3 - New forms of active pharmaceutical ingredient - Google Patents

New forms of active pharmaceutical ingredient Download PDF

Info

Publication number
WO2007135406A3
WO2007135406A3 PCT/GB2007/001870 GB2007001870W WO2007135406A3 WO 2007135406 A3 WO2007135406 A3 WO 2007135406A3 GB 2007001870 W GB2007001870 W GB 2007001870W WO 2007135406 A3 WO2007135406 A3 WO 2007135406A3
Authority
WO
WIPO (PCT)
Prior art keywords
active pharmaceutical
pharmaceutical ingredient
new forms
forms
entacapone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2007/001870
Other languages
French (fr)
Other versions
WO2007135406A2 (en
Inventor
Dijana Skalec Semec
Marina Marinkovic
Zvonimir Siljkovic
Michaela Horvat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pliva Hrvatska doo
Pliva Istrazivanje i Razvoj doo
Original Assignee
Pliva Hrvatska doo
Pliva Istrazivanje i Razvoj doo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Hrvatska doo, Pliva Istrazivanje i Razvoj doo filed Critical Pliva Hrvatska doo
Publication of WO2007135406A2 publication Critical patent/WO2007135406A2/en
Publication of WO2007135406A3 publication Critical patent/WO2007135406A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention is concerned with new polymorphic forms of entacapone, in particular new polymorphic forms α, β, γ, δ, ε, τ and the amorphous form of entacapone, processes of preparing the forms, pharmaceutical compositions containing the same, therapeutic uses thereof and methods of treatment employing the same.
PCT/GB2007/001870 2006-05-23 2007-05-21 New forms of active pharmaceutical ingredient Ceased WO2007135406A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0610207.3A GB0610207D0 (en) 2006-05-23 2006-05-23 New forms of active pharmaceutical ingredient
GB0610207.3 2006-05-23

Publications (2)

Publication Number Publication Date
WO2007135406A2 WO2007135406A2 (en) 2007-11-29
WO2007135406A3 true WO2007135406A3 (en) 2008-01-17

Family

ID=36687563

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2007/001870 Ceased WO2007135406A2 (en) 2006-05-23 2007-05-21 New forms of active pharmaceutical ingredient

Country Status (2)

Country Link
GB (1) GB0610207D0 (en)
WO (1) WO2007135406A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20062450A1 (en) 2006-12-19 2008-06-20 Dipharma Spa PROCEDURE FOR THE PREPARATION OF ENTACAPONE

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135950A (en) * 1989-11-03 1992-08-04 Orion-Yhtyma Oy Stable polymorphic form of (e)-n,n-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide and the process for its preparation
US5446194A (en) * 1986-11-28 1995-08-29 Orion-Yhtyma Oy Pharmacologically active catechol derivatives
WO2005063696A2 (en) * 2003-12-31 2005-07-14 Cilag Ag Novel crystalline forms of entacapone and production thereof
WO2005066117A1 (en) * 2003-12-29 2005-07-21 Wockhardt Limited Stable polymorphs of (e)-n,n-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446194A (en) * 1986-11-28 1995-08-29 Orion-Yhtyma Oy Pharmacologically active catechol derivatives
US5135950A (en) * 1989-11-03 1992-08-04 Orion-Yhtyma Oy Stable polymorphic form of (e)-n,n-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide and the process for its preparation
WO2005066117A1 (en) * 2003-12-29 2005-07-21 Wockhardt Limited Stable polymorphs of (e)-n,n-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide
WO2005063696A2 (en) * 2003-12-31 2005-07-14 Cilag Ag Novel crystalline forms of entacapone and production thereof

Also Published As

Publication number Publication date
WO2007135406A2 (en) 2007-11-29
GB0610207D0 (en) 2006-07-05

Similar Documents

Publication Publication Date Title
WO2009056550A3 (en) Bupropion hydrobromide and therapeutic applications
WO2010003313A8 (en) Icotinib hydrochloride, synthesis, crystallographic form, medical combination, and uses thereof
IL184712A (en) Pyrazolo-pyrimidine derivatives, process of their manufacture, pharmaceutical compositions comprising them and use for the preparation of medicaments
WO2008030818A3 (en) Novel liposome compositions
WO2006055511A3 (en) Stable tablet formulation of tetrahydrobiopterin
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
IL220682A0 (en) 1h-quinazoline-2,4-diones, processes for their manufacture, and use thereof in the preparation of medicaments for treating conditions mediated by the ampa-receptor
WO2008116139A3 (en) N-heterocyclic compounds useful as inhibitors of janus kinases
IL179758A0 (en) Substituted tetrahydro - 2h - isoquinolin - 1 - one derivatives, method for the production thereof, and use of the same as medicaments
WO2009019294A3 (en) Bupropion hydrobromide and therapeutic applications
PL1752443T3 (en) New crystalline form V of agometaline, the process for its preparation and the pharmaceutical compositions containing it
WO2007144169A3 (en) Entacapone-derivatives
IL179611A (en) 1-aza-bicycloalkyl derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof for the preparation of medicaments for the treatment of psychotic disorders
ZA200801896B (en) Slow-release composition, method for the preparation thereof, and use of the same
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
WO2006018184A3 (en) Spirocyclic cyclohexane derivatives
ZA201003794B (en) Novel 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation
WO2007011639A3 (en) Catalytic immunoglobulins
WO2009142428A3 (en) Pharmaceutical composition for the treatment of premature ejaculation
PL2059503T3 (en) Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same
SI1750700T1 (en) Liquid preparation for veterinary medicine, method for the production thereof, and use of the same
WO2008157563A3 (en) Deuterium-enriched clopidogrel
WO2007025146A3 (en) Balsalazide formulations and manufacture and use thereof
WO2006044753A3 (en) Chemical compounds
WO2008130319A3 (en) Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07732891

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07732891

Country of ref document: EP

Kind code of ref document: A2